News

mark-harpur-d8yPxlVERM8-unsplash-news

November 21, 2021

Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor

Read More

May 3, 2021

Zenas BioPharma Announces New Executive Leadership Appointments

Read More

March 23, 2021

Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Development and Delivery of Immune-Based Therapies

Read More
long-arrow-right-regularfacebook-brandsfacebook-f-brandsinstagram-brandslinkedin-brandslinkedin-in-brandssubmit-arrowtwitter-brandstwitter-square-brandsyoutube-brands